+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Pharmacotherapy of cardiac arrhythmias--basic science for clinicians



Pharmacotherapy of cardiac arrhythmias--basic science for clinicians



Pacing and Clinical Electrophysiology 32(11): 1454-1465



Cardiac arrhythmias occur in approximately 5.3% of the population and contribute substantially to morbidity and mortality. Pharmacological therapy still remains the major approach in management of patients with nearly every form of cardiac arrhythmia. Effective and safe management of cardiac arrhythmias with antiarrhythmic drugs requires understanding of basic mechanisms for various cardiac arrhythmias, clinical diagnosis of an arrhythmia and identification of underlying cardiac diseases, pharmacokinetics, and antiarrhythmic properties of each individual antiarrhythmic drug. Most cardiac arrhythmias occur via one of the two mechanisms: abnormal impulse formation and reentry or both. Antiarrhythmic drugs primarily work via influencing cardiac automaticity or triggered activity or by their effects on effective refractoriness of cardiac cells. Proarrhythmic effects of antiarrhythmic drugs are also briefly discussed in this review article.

(PDF emailed within 0-6 h: $19.90)

Accession: 054963487

Download citation: RISBibTeXText

PMID: 19744278

DOI: 10.1111/j.1540-8159.2009.02526.x


Related references

How much do we understand about pharmacotherapy of cardiac arrhythmias?. Lijecnicki Vjesnik 115(5-6): 156-159, 1993

Basis of pharmacotherapy of cardiac arrhythmias. Modern Concepts of Cardiovascular Disease 31: 739-744, 1962

Basic science for clinicians. New England Journal of Medicine 302(14): 805-806, 1980

Basic science for clinicians. Journal of Clinical Rheumatology 8(1): 60-60, 2002

Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias (JCS 2011). Circulation Journal 77(1): 249-274, 2013

Pharmacotherapy of cardiac arrhythmias in women--what do we know, do we have a choice?. Przeglad Lekarski 71(3): 155-159, 2014

Should basic science matter to clinicians?. Lancet 391(10119): 410-412, 2018

Neuropsychiatric sequelae of pharmacotherapy of cardiac arrhythmias and hypertension. Journal of Clinical Psychopharmacology 1(6): 394-398, 1981

Pharmacotherapy of cardiac arrhythmias in acute myocardial infarction. Folia Medica Neerlandica 14(5): 225-236, 1971

Basic clinicians: on the marriage between clinicians and basic scientists at AHRI/ALERT (Armauer Hansen Research Institute/All Africa Leprosy and Rehabilitation Training Centre). Leprosy Review 57 Suppl 1: 81-87, 1986

Basic science review on adipose tissue for clinicians. Plastic and Reconstructive Surgery 128(3): 829-830, 2011

The basic science of platelet-rich plasma (PRP): what clinicians need to know. Sports Medicine and Arthroscopy Review 21(4): 180-185, 2014

REVIEW: Oxytocin: Crossing the bridge between basic science and pharmacotherapy. Cns Neuroscience & Therapeutics 16(5): E138-E156, 2011

Translating basic science to improve pharmacotherapy for nicotine dependence. Nicotine & Tobacco Research 9 Suppl 4: S583-S598, 2008

The oculomotor periphery The clinicians focus is no longer a basic science stepchild. Current Opinion in Neurobiology 7(6): 880-887, 1997